{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:35:34Z","timestamp":1765960534644,"version":"3.48.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015447","name":"Auckland District Health Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.clim.2024.110320","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T21:09:35Z","timestamp":1721855375000},"page":"110320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency Disorders"],"prefix":"10.1016","volume":"266","author":[{"given":"Rohan","family":"Ameratunga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Longhurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Euphemia","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Steele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Lehnert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"See-Tarn","family":"Woon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2024.110320_bb0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.iac.2020.03.001","article-title":"Defining common variable immunodeficiency disorders in 2020","volume":"40","author":"Ameratunga","year":"2020","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"10.1016\/j.clim.2024.110320_bb0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imr.12728","article-title":"Common variable immune deficiency: dissection of the variable","volume":"287","author":"Cunningham-Rundles","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2024.110320_bb0015","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3389\/fimmu.2018.02130","article-title":"Assessing disease severity in common variable immunodeficiency disorders (CVID) and CVID-like disorders","volume":"9","author":"Ameratunga","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13223-019-0383-9","article-title":"The critical role of histology in distinguishing sarcoidosis from common variable immunodeficiency disorder (CVID) in a patient with hypogammaglobulinemia","volume":"15","author":"Ameratunga","year":"2019","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0030","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3389\/fimmu.2018.00694","article-title":"Delayed diagnosis and complications of predominantly antibody deficiencies in a cohort of Australian adults","volume":"9","author":"Slade","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0035","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/cei.13595","article-title":"Bronchiectasis is associated with delayed diagnosis and adverse outcomes in the New Zealand common variable immunodeficiency disorders cohort study","volume":"204","author":"Ameratunga","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0040","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3389\/fimmu.2020.00522","article-title":"Bronchiectasis in primary antibody deficiencies: a multidisciplinary approach","volume":"11","author":"Wall","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0045","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3389\/fimmu.2017.01190","article-title":"Unexpectedly high prevalence of common variable immunodeficiency in Finland","volume":"8","author":"Selenius","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0050","doi-asserted-by":"crossref","first-page":"8416124","DOI":"10.1155\/2020\/8416124","article-title":"Global distribution of common variable immunodeficiency (CVID) in the light of the UNDP human development index (HDI): a preliminary perspective of a rare disease","volume":"2020","author":"Weifenbach","year":"2020","journal-title":"J Immunol Res"},{"key":"10.1016\/j.clim.2024.110320_bb0055","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/587669","article-title":"Infections in 252 patients with common variable immunodeficiency","volume":"46","author":"Oksenhendler","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2024.110320_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140473","article-title":"The incidence and prevalence of common variable immunodeficiency disease in Taiwan, a population-based study","volume":"10","author":"Tseng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2024.110320_bb0070","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3346\/jkms.2012.27.7.788","article-title":"Prevalence of primary immunodeficiency in Korea","volume":"27","author":"Rhim","year":"2012","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.clim.2024.110320_bb0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12016-019-08765-6","article-title":"Perspective: evolving concepts in the diagnosis and understanding of common variable immunodeficiency disorders (CVID)","volume":"59","author":"Ameratunga","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41436-018-0012-x","article-title":"Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency","volume":"21","author":"Abolhassani","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.clim.2024.110320_bb0085","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.jaci.2017.06.049","article-title":"Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency","volume":"141","author":"Abolhassani","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0090","first-page":"1","article-title":"Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"24","author":"Tangye","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0095","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10875-019-00735-z","article-title":"Expanding clinical phenotype and novel insights into the pathogenesis of ICOS deficiency","volume":"40","author":"Abolhassani","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/1744666X.2018.1481750","article-title":"Keeping it in the family: the case for considering late-onset combined immunodeficiency a subset of common variable immunodeficiency disorders","volume":"14","author":"Ameratunga","year":"2018","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0105","article-title":"Severe COVID-19 represents an undiagnosed primary immunodeficiency in a high proportion of infected individuals","volume":"11","author":"Gray","year":"2022","journal-title":"Clini. & Translation. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.coi.2021.06.004","article-title":"TACI deficiency \u2014 a complex system out of balance","volume":"71","author":"Salzer","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0115","first-page":"00174","article-title":"The rapidly expanding genetic spectrum of common variable immunodeficiency-like disorders","volume":"14","author":"Ameratunga","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clim.2024.110320_bb0120","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng0407-429","article-title":"Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency","volume":"39","author":"Pan-Hammarstrom","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2024.110320_bb0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10875-012-9793-x","article-title":"Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI)","volume":"33","author":"Koopmans","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2017.41","article-title":"Epistatic interactions between mutations of TACI (TNFRSF13B) and TCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus","volume":"6","author":"Ameratunga","year":"2017","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0135","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3389\/fimmu.2017.01965","article-title":"Clinical implications of Digenic inheritiance and epistasis in primary immunodeficiency disorders","volume":"8","author":"Ameratunga","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0140","first-page":"22","article-title":"Discussion on the influence of heredity on disease, with special reference to tuberculosis, Cancer, and diseases of the nervous system: introductory address","volume":"2","author":"Bateson.","year":"1909","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.clim.2024.110320_bb0145","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1038\/ncomms8335","article-title":"Monozygotic twins discordant for common variable immunodeficiency reveal impaired DNA demethylation during naive-to-memory B-cell transition","volume":"6","author":"Rodriguez-Cortez","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2024.110320_bb0150","first-page":"46","article-title":"Customised molecular diagnosis of primary immune deficiency disorders in New Zealand: an efficient strategy for a small developed country","volume":"122","author":"Ameratunga","year":"2009","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.clim.2024.110320_bb0155","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.3389\/fimmu.2019.02678","article-title":"All patients with common variable immunodeficiency disorders (CVID) should be routinely offered diagnostic genetic testing","volume":"10","author":"Ameratunga","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/1744666X.2014.870478","article-title":"Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?","volume":"10","author":"Seppanen","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0165","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/cei.12178","article-title":"New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin","volume":"174","author":"Ameratunga","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110320_bb0175","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clim.2024.110320_bb0180","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clim.2024.110320_bb0185","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.clim.2007.04.011","article-title":"Active vaccination in patients with common variable immunodeficiency (CVID)","volume":"124","author":"Goldacker","year":"2007","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0190","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/CVI.00101-12","article-title":"Immune response to Haemophilus influenzae type b vaccination in patients with chronic renal failure","volume":"19","author":"Hawdon","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0195","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3389\/fimmu.2019.01541","article-title":"The natural history of untreated primary Hypogammaglobulinemia in adults: implications for the diagnosis and treatment of common variable immunodeficiency disorders (CVID)","volume":"10","author":"Ameratunga","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0200","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fimmu.2014.00415","article-title":"Comparison of diagnostic criteria for common variable immunodeficiency disorder","volume":"5","author":"Ameratunga","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0205","first-page":"U914","article-title":"The assessment and management of primary antibody deficiency","volume":"117","author":"Empson","year":"2004","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.clim.2024.110320_bb0210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10875-012-9806-9","article-title":"Serotype-specific anti-pneumococcal IgG and immune competence: critical differences in interpretation criteria when different methods are used","volume":"33","author":"Balloch","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0215","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/0004563213500241","article-title":"Making sense of serotype-specific pneumococcal antibody measurements","volume":"50","author":"Beck","year":"2013","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clim.2024.110320_bb0220","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.vaccine.2010.10.046","article-title":"Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age","volume":"29","author":"Russell","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2024.110320_bb0225","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/CVI.13.3.356-360.2006","article-title":"Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera","volume":"13","author":"Henckaerts","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0230","first-page":"75","article-title":"The case for a national service for primary immune deficiency disorders in New Zealand","volume":"129","author":"Ameratunga","year":"2016","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.clim.2024.110320_bb0235","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12016-021-08860-7","article-title":"Comparison of diagnostic criteria for common variable immunodeficiency disorders (CVID) in the New Zealand CVID cohort study","volume":"61","author":"Ameratunga","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0240","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/cei.13345","article-title":"Transient hypogammaglobulinaemia of infancy: many patients recover in adolescence and adulthood","volume":"198","author":"Ameratunga","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0245","first-page":"9","article-title":"Munchausen syndrome presenting as common variable immune deficiency","author":"Ameratunga","year":"2013","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0250","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10875-015-0189-6","article-title":"Profound reversible Hypogammaglobulinemia caused by celiac disease in the absence of protein losing enteropathy","volume":"35","author":"Ameratunga","year":"2015","journal-title":"J. Clin. Immunol."},{"issue":"283\u20134","key":"10.1016\/j.clim.2024.110320_bb0255","article-title":"Vaccines in the assessment of patients for immune deficiency","volume":"130","author":"Ballow","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0260","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","article-title":"Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the basic and clinical immunology interest section of the American Academy of Allergy, Asthma & Immunology","volume":"130","author":"Orange","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0265","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/sji.12028","article-title":"Variability of memory B cell markers in a cohort of common variable immune deficiency patients over 6 months","volume":"77","author":"Koopmans","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0270","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40272-023-00584-9","article-title":"20-Valent Pneumococcal Conjugate Vaccine: Pediatric First Approval","volume":"25","author":"Shirley","year":"2023","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.clim.2024.110320_bb0275","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1754.1997.tb01016.x","article-title":"The immunogenicity of Haemophilus influenzae: meningococcal protein conjugate vaccine in Polynesian and non-Polynesian New Zealand infants","volume":"33","author":"Ameratunga","year":"1997","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.clim.2024.110320_bb0280","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.46.20313-en","article-title":"Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009","volume":"17","author":"Ladhani","year":"2012","journal-title":"Euro Surveill."},{"key":"10.1016\/j.clim.2024.110320_bb0285","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.2004.02439.x","article-title":"Development of an anti-salmonella typhi vi ELISA: assessment of immunocompetence in healthy donors","volume":"136","author":"Ferry","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2018.05.013","article-title":"Measurement and interpretation of salmonella typhi vi IgG antibodies for the assessment of adaptive immunity","volume":"459","author":"Parker","year":"2018","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.clim.2024.110320_bb0295","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3389\/fimmu.2019.00986","article-title":"A critical view of specific antibody deficiencies","volume":"10","author":"Sorensen","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0300","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"145","author":"Chapel","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clim.2024.110320_bb0305","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1016\/j.vaccine.2012.06.073","volume":"30","author":"Thierry-Carstensen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2024.110320_bb0310","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fimmu.2014.00410","article-title":"Diagnostic immunization with bacteriophage PhiX 174 in patients with common variable immunodeficiency\/Hypogammaglobulinemia","volume":"5","author":"Smith","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0315","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1023\/B:JOCI.0000010429.36461.6b","article-title":"Vaccination with rabies to study the humoral and cellular immune response to a T-cell dependent neoantigen in man","volume":"23","author":"Brinkman","year":"2003","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0320","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1172\/JCI106756","article-title":"Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases","volume":"50","author":"Ochs","year":"1971","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2024.110320_bb0325","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/sji.12551","article-title":"Identification and characterization of a Nationwide Danish adult common variable immunodeficiency cohort","volume":"85","author":"Westh","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0330","doi-asserted-by":"crossref","first-page":"129","DOI":"10.15586\/aei.v50i4.496","article-title":"Application of the diagnostic criteria for common variable immunodeficiency in resource-limited settings","volume":"50","author":"\u00c1lvarez-\u00c1lvarez","year":"2022","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.clim.2024.110320_bb0335","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajhg.2015.07.008","article-title":"Haploinsufficiency of the NF-kappaB1 subunit p50 in common variable immunodeficiency","volume":"97","author":"Fliegauf","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2024.110320_bb0340","first-page":"051","article-title":"Characterization of the clinical and immunological phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations","volume":"9","author":"Lorenzini","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110320_bb0345","article-title":"The autoimmune rheumatological presentation of common variable immunodeficiency disorders with an overview of genetic testing","volume":"152387","author":"Ameratunga","year":"2024","journal-title":"Semin. Arthritis Rheum."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624004297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624004297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:26:23Z","timestamp":1765959983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661624004297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":69,"alternative-id":["S1521661624004297"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2024.110320","relation":{},"ISSN":["1521-6616"],"issn-type":[{"type":"print","value":"1521-6616"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency Disorders","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2024.110320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110320"}}